This is a Validated Antibody Database (VAD) review about human CEACAM1, based on 17 published articles (read how Labome selects the articles), using CEACAM1 antibody in all methods. It is aimed to help Labome visitors find the most suited CEACAM1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CEACAM1 synonym: BGP; BGP1; BGPI

R&D Systems
mouse monoclonal (283340)
  • flow cytometry; human; loading ...; fig st8
R&D Systems CEACAM1 antibody (R&D Systems, MAB2244) was used in flow cytometry on human samples (fig st8). Oncoimmunology (2022) ncbi
Santa Cruz Biotechnology
mouse monoclonal (E-10)
  • western blot; human
Santa Cruz Biotechnology CEACAM1 antibody (Santa Cruz Biotechnology, sc-166404) was used in western blot on human samples . Tumour Biol (2015) ncbi
mouse monoclonal (GM8G5)
  • immunoprecipitation; human; 1 ug
In order to examine the association between CEACAM1 isoform balance and hepatocellular carcinoma malignant potential and investigate the molecular interaction between CEACAM1 and beta2SP, Santa Cruz Biotechnology CEACAM1 antibody (Santa Cruz Biotechnology, GM8G5) was used in immunoprecipitation on human samples at 1 ug. Ann Surg Oncol (2014) ncbi
mouse monoclonal (GM8G5)
  • immunoprecipitation; human
In order to test if beta-HPV gene products are present in lesions from kidney transplant recipients, Santa Cruz Biotechnology CEACAM1 antibody (Santa Cruz Biotechnology, GM8G5) was used in immunoprecipitation on human samples . Mod Pathol (2014) ncbi
Invitrogen
mouse monoclonal (283340)
  • flow cytometry; human; loading ...; fig 5e
Invitrogen CEACAM1 antibody (ThermoFisher Scientific, 283340) was used in flow cytometry on human samples (fig 5e). Cell Death Dis (2021) ncbi
Miltenyi Biotec
mouse monoclonal (TET2)
  • flow cytometry; rhesus macaque; loading ...; fig 1a
In order to examine frequency and function of myeloid-derived suppressor cells in SIV-infected rhesus macaques, Miltenyi Biotec CEACAM1 antibody (Miltenyi Biotec, TET2) was used in flow cytometry on rhesus macaque samples (fig 1a). J Immunol (2017) ncbi
Dako
mouse monoclonal (II-7)
  • immunohistochemistry; human; 1:40; loading ...; fig 1f
Dako CEACAM1 antibody (DAKO, II-7) was used in immunohistochemistry on human samples at 1:40 (fig 1f). Diagn Pathol (2019) ncbi
mouse monoclonal (II-7)
  • immunohistochemistry; human; 0.2 ug/ml; tbl 2
In order to measure the extent of squamous metaplasia in bronchial biopsies and correlate it to the presence of chronic obstructive pulmonary disease, Dako CEACAM1 antibody (Dako, M7072) was used in immunohistochemistry on human samples at 0.2 ug/ml (tbl 2). PLoS ONE (2016) ncbi
mouse monoclonal (II-7)
  • immunohistochemistry; human; fig 4
Dako CEACAM1 antibody (Dako, II-7) was used in immunohistochemistry on human samples (fig 4). Br J Cancer (2016) ncbi
mouse monoclonal (II-7)
  • immunohistochemistry - paraffin section; human
In order to characterize two cases of primary thymic adenocarcinoma with enteric differentiation, Dako CEACAM1 antibody (Dako, clone II-7) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2015) ncbi
mouse monoclonal (II-7)
  • immunohistochemistry - paraffin section; human; 1:400
Dako CEACAM1 antibody (Dako, M7072) was used in immunohistochemistry - paraffin section on human samples at 1:400. Virchows Arch (2014) ncbi
Cell Signaling Technology
mouse monoclonal (CB30)
  • immunohistochemistry - paraffin section; mouse; fig 4
Cell Signaling Technology CEACAM1 antibody (Cell Signaling, CB30) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Oncoimmunology (2016) ncbi
mouse monoclonal (CB30)
  • western blot; mouse; 1:500
Cell Signaling Technology CEACAM1 antibody (Cell Signaling Technologies, 2383) was used in western blot on mouse samples at 1:500. Cardiovasc Diabetol (2015) ncbi
mouse monoclonal (CB30)
  • western blot; mouse; 1:500
Cell Signaling Technology CEACAM1 antibody (Cell Signaling Technologies, 2383) was used in western blot on mouse samples at 1:500. BMC Endocr Disord (2015) ncbi
mouse monoclonal (CB30)
  • western blot; human
Cell Signaling Technology CEACAM1 antibody (Cell Signaling, 2383) was used in western blot on human samples . Tumour Biol (2015) ncbi
BD Biosciences
mouse monoclonal (B1.1/CD66)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CEACAM1 antibody (BD Biosciences, 551480) was used in flow cytometry on human samples (fig 1c). EMBO Mol Med (2016) ncbi
mouse monoclonal (B1.1/CD66)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CEACAM1 antibody (BD, 551480) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (B1.1/CD66)
  • flow cytometry; human; 1:1000
In order to compared leukocyte proportions and absolute counts using reference real-time methods with a novel assay that allows long-term cryopreservation of fixed leukocytes for later counting, BD Biosciences CEACAM1 antibody (BD, 551479) was used in flow cytometry on human samples at 1:1000. Cytometry A (2015) ncbi
Articles Reviewed
  1. Pinkert J, Boehm H, Trautwein M, Doecke W, Wessel F, Ge Y, et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology. 2022;11:2008110 pubmed publisher
  2. Lake C, Voss K, Bauman B, Pohida K, Jiang T, Dveksler G, et al. TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1. Cell Death Dis. 2021;12:400 pubmed publisher
  3. Oyama Y, Nishida H, Kusaba T, Kadowaki H, Arakane M, Okamoto K, et al. Colon adenoma and adenocarcinoma with clear cell components - two case reports. Diagn Pathol. 2019;14:37 pubmed publisher
  4. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed publisher
  5. Wang L, Ma N, Okamoto S, Amaishi Y, Sato E, Seo N, et al. Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome. Oncoimmunology. 2016;5:e1211218 pubmed
  6. Li L, Qi X, Sun W, Abdel Azim H, Lou S, Zhu H, et al. Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality. EMBO Mol Med. 2016;8:1340-1359 pubmed publisher
  7. Rigden H, Alias A, Havelock T, O Donnell R, Djukanovic R, Davies D, et al. Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016;11:e0156009 pubmed publisher
  8. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  9. Ohlsson L, Hammarström M, Lindmark G, Hammarström S, Sitohy B. Ectopic expression of the chemokine CXCL17 in colon cancer cells. Br J Cancer. 2016;114:697-703 pubmed publisher
  10. He J, Quintana M, Sullivan J, L Parry T, J Grevengoed T, Schisler J, et al. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. Cardiovasc Diabetol. 2015;14:97 pubmed publisher
  11. Quintana M, He J, Sullivan J, Grevengoed T, Schisler J, Han Y, et al. Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet. BMC Endocr Disord. 2015;15:36 pubmed publisher
  12. Moser B, Schiefer A, Janik S, Marx A, Prosch H, Pohl W, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39:541-8 pubmed publisher
  13. Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W, et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65 pubmed publisher
  14. Aqil M, Elseth K, Arjunakani A, Nebres P, Amegashie C, Thanki D, et al. A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties. Tumour Biol. 2015;36:1871-9 pubmed publisher
  15. Seipel A, Samaratunga H, Delahunt B, Wiklund F, Wiklund P, Lindberg J, et al. Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch. 2014;465:559-65 pubmed publisher
  16. Kiriyama S, Yokoyama S, Ueno M, Hayami S, Ieda J, Yamamoto N, et al. CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma. Ann Surg Oncol. 2014;21 Suppl 4:S505-14 pubmed publisher
  17. Borgogna C, Lanfredini S, Peretti A, de Andrea M, Zavattaro E, Colombo E, et al. Improved detection reveals active ?-papillomavirus infection in skin lesions from kidney transplant recipients. Mod Pathol. 2014;27:1101-15 pubmed publisher